MANGALAM GLOBAL ENTERPRISE
Back to Balance Sheet
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹147 Cr | ₹185 Cr | ₹184 Cr | ₹170 Cr | ₹45 Cr |
What is the latest Contingent Liabilities ratio of MANGALAM GLOBAL ENTERPRISE ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹147 Cr |
| Mar2025 | ₹185 Cr |
| Mar2024 | ₹184 Cr |
| Mar2023 | ₹170 Cr |
| Mar2022 | ₹45 Cr |
How is Contingent Liabilities of MANGALAM GLOBAL ENTERPRISE Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹147 Cr | -20.82 | |
| Mar2025 | ₹185 Cr | 0.84 | |
| Mar2024 | ₹184 Cr | 8.01 | |
| Mar2023 | ₹170 Cr | 273.61 | |
| Mar2022 | ₹45 Cr | - | |
Compare Contingent Liabilities of peers of MANGALAM GLOBAL ENTERPRISE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANGALAM GLOBAL ENTERPRISE | ₹586.7 Cr | 2.1% | 10.1% | 27.7% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,743.7 Cr | 5% | 0.8% | -28.3% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,186.6 Cr | -2.9% | -8.7% | 18.6% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,468.0 Cr | -3.9% | -2.4% | 42.5% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹919.7 Cr | -3.1% | -9% | NA | Stock Analytics | |
| NATH BIOGENES (INDIA) | ₹270.7 Cr | 3.1% | 2% | -15.9% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANGALAM GLOBAL ENTERPRISE | 2.1% |
10.1% |
27.7% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses